Results 21 to 30 of about 183,516 (347)

IL-11 system participates in pulmonary artery remodeling and hypertension in pulmonary fibrosis

open access: yesRespiratory Research, 2022
Background Pulmonary hypertension (PH) associated to idiopathic pulmonary fibrosis (IPF) portends a poor prognosis. IL-11 has been implicated in fibrotic diseases, but their role on pulmonary vessels is unknown. Here we analyzed the contribution of IL-11
Javier Milara   +5 more
doaj   +1 more source

Characterization of pulmonary vascular remodeling and MicroRNA-126-targets in COPD-pulmonary hypertension

open access: yesRespiratory Research, 2022
Background Despite causing increased morbidity and mortality, pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD) patients (COPD-PH) lacks treatment, due to incomplete understanding of its pathogenesis.
Khushboo Goel   +11 more
doaj   +1 more source

Loss of family with sequence similarity 13, member A exacerbates pulmonary hypertension through accelerating endothelial-to-mesenchymal transition.

open access: yesPLoS ONE, 2020
Pulmonary hypertension is a progressive lung disease with poor prognosis due to the consequent right heart ventricular failure. Pulmonary artery remodeling and dysfunction are culprits for pathologically increased pulmonary arterial pressure, but their ...
Pranindya Rinastiti   +7 more
doaj   +1 more source

NETs Activate Pulmonary Arterial Endothelial Cells [PDF]

open access: yesArteriosclerosis, Thrombosis, and Vascular Biology, 2016
The article by Aldabbous et al1 describes neutrophil extracellular traps (NETs) as a novel feature related to the vascular pathology of both pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). NETs were originally identified as a suicide mechanism whereby neutrophil elastase degrades and releases chromatin ...
openaire   +2 more sources

Monocrotaline Induces Endothelial Injury and Pulmonary Hypertension by Targeting the Extracellular Calcium–Sensing Receptor

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundMonocrotaline has been widely used to establish an animal model of pulmonary hypertension. The molecular target underlying monocrotaline‐induced pulmonary artery endothelial injury and pulmonary hypertension remains unknown.
Rui Xiao   +10 more
doaj   +1 more source

Influence of Rho Kinase Inhibitor Fasudil on Late Endothelial Progenitor Cells in Peripheral Blood of COPD Patients with Pulmonary Artery Hypertension

open access: yesBiomolecules & Biomedicine, 2014
The objective of our work was to investigate the influence of Fasudil, a Rho inhibitor on the number and function of the late endothelial progenitor cells in peripheral blood of chronic obstructive pulmonary diseases (COPD) patients with pulmonary ...
Pei Liu   +5 more
doaj   +1 more source

Platelet kinetics in the pulmonary microcirculation in vivo assessed by intravital microscopy [PDF]

open access: yes, 2002
Growing evidence supports the substantial pathophysiological impact of platelets on the development of acute lung injury. Methods for studying these cellular mechanisms in vivo are not present yet.
Eichhorn, M. E.   +3 more
core   +1 more source

Hypoxia Preconditioning Increases Survival and Decreases Expression of Toll-like Receptor 4 in Pulmonary Artery Endothelial Cells Exposed to Lipopolysaccharide [PDF]

open access: yes, 2013
Pulmonary or systemic infections and hypoxemic respiratory failure are among the leading causes of admission to intensive care units, and these conditions frequently exist in sequence or in tandem.
Ali, Irshad   +7 more
core   +2 more sources

Senescence Alterations in Pulmonary Hypertension

open access: yesCells, 2021
Cellular senescence is the arrest of normal cell division and is commonly associated with aging. The interest in the role of cellular senescence in lung diseases derives from the observation of markers of senescence in chronic obstructive pulmonary ...
Inés Roger   +3 more
doaj   +1 more source

Pneumolysin activates phospholipase A in pulmonary artery endothelial cells [PDF]

open access: yesInfection and Immunity, 1994
Pneumolysin has been identified as a virulence factor in Streptococcus pneumoniae disease. In addition to producing tissue injury through its cytolytic effect, pneumolysin might injure tissues indirectly by eliciting an inflammatory response. We demonstrate for the first time that pneumolysin is a rapid and potent activator of cellular phospholipase A ...
J B, Rubins   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy